Literature DB >> 20241608

Fibrinolytic activity of normal urine.

R G MACFARLANE, J PILLING.   

Abstract

Keywords:  BLOOD/fibrin; URINE/fibrinolytic activity

Mesh：

Substances：

Year:  1947        PMID： 20241608     DOI： 10.1038/159779a0

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  17 in total

1.  [STUDIES ON THE PROTEOLYTIC ACTIVITY OF URINE FROM GUINEA PIGS IN ALLERGIC REACTIONS].

Authors:  E KAISER; W RAAB; W LEPIER
Journal:  Arch Klin Exp Dermatol       Date:  1964-09-10

2.  On the controlling function of the kidneys in fibrinolysis.

Authors:  K BULUK; M FURMAN
Journal:  Experientia       Date:  1962-03-15

3.  Review of pharmacology and physiology in thrombolysis interventions.

Authors:  M Grace Knuttinen; Neelmini Emmanuel; Furquaan Isa; Alex W Rogers; Ron C Gaba; James T Bui; Charles A Owens
Journal:  Semin Intervent Radiol       Date:  2010-12       Impact factor: 1.513

Review 4.  Translational initiatives in thrombolytic therapy.

Authors:  Melvin E Klegerman
Journal:  Front Med       Date:  2017-03-02       Impact factor: 4.592

Review 5.  Pulmonary embolism: current therapeutic concepts.

Authors:  D A Tibbutt; C N Chesterman
Journal:  Drugs       Date:  1976       Impact factor: 9.546

Review 6.  Urinary serine proteases and activation of ENaC in kidney--implications for physiological renal salt handling and hypertensive disorders with albuminuria.

Authors:  Per Svenningsen; Henrik Andersen; Lise H Nielsen; Boye L Jensen
Journal:  Pflugers Arch       Date:  2014-12-09       Impact factor: 3.657

7.  Fibrinolytic activity in renal venous blood in man.

Authors:  J Schrader; K L Neuhaus; U Tebbe; H Köstering; F Scheler
Journal:  Klin Wochenschr       Date:  1986-07-01

8.  Urokinase plasminogen activator system-targeted delivery of nanobins as a novel ovarian cancer therapy.

Authors:  Yilin Zhang; Hilary A Kenny; Elden P Swindell; Anirban K Mitra; Patrick L Hankins; Richard W Ahn; Katja Gwin; Andrew P Mazar; Thomas V O'Halloran; Ernst Lengyel
Journal:  Mol Cancer Ther       Date:  2013-09-23       Impact factor: 6.261

Review 9.  Thrombolytic Agents: Nanocarriers in Controlled Release.

Authors:  Soodabeh Hassanpour; Han-Jun Kim; Arezoo Saadati; Peyton Tebon; Chengbin Xue; Floor W van den Dolder; Jai Thakor; Behzad Baradaran; Jafar Mosafer; Amir Baghbanzadeh; Natan Roberto de Barros; Mahmoud Hashemzaei; Kang Ju Lee; Junmin Lee; Shiming Zhang; Wujin Sun; Hyun-Jong Cho; Samad Ahadian; Nureddin Ashammakhi; Mehmet R Dokmeci; Ahad Mokhtarzadeh; Ali Khademhosseini
Journal:  Small       Date:  2020-08-12       Impact factor: 13.281

Review 10.  Fibrinolytic Enzymes for Thrombolytic Therapy.

Authors:  Swaroop S Kumar; Abdulhameed Sabu
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.